These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17346157)

  • 1. Insights into oxidative stress: the isoprostanes.
    Montuschi P; Barnes P; Roberts LJ
    Curr Med Chem; 2007; 14(6):703-17. PubMed ID: 17346157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
    Musiek ES; Yin H; Milne GL; Morrow JD
    Lipids; 2005 Oct; 40(10):987-94. PubMed ID: 16382569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo.
    Yin H
    Biofactors; 2008; 34(2):109-24. PubMed ID: 19706977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The isoprostanes: unique bioactive products of lipid peroxidation.
    Morrow JD; Roberts LJ
    Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.
    Milatovic D; Aschner M
    Curr Protoc Toxicol; 2009 Feb; Chapter 12(Supplement 39):Unit12.14. PubMed ID: 20191108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprostanes: markers and mediators of oxidative stress.
    Montuschi P; Barnes PJ; Roberts LJ
    FASEB J; 2004 Dec; 18(15):1791-800. PubMed ID: 15576482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F2-isoprostanes are not just markers of oxidative stress.
    Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C
    Free Radic Biol Med; 2008 Feb; 44(3):247-56. PubMed ID: 17997380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans.
    Yin H; Gao L; Tai HH; Murphey LJ; Porter NA; Morrow JD
    J Biol Chem; 2007 Jan; 282(1):329-36. PubMed ID: 17107953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.
    Morrow JD
    Curr Pharm Des; 2006; 12(8):895-902. PubMed ID: 16533158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase.
    Gao L; Zackert WE; Hasford JJ; Danekis ME; Milne GL; Remmert C; Reese J; Yin H; Tai HH; Dey SK; Porter NA; Morrow JD
    J Biol Chem; 2003 Aug; 278(31):28479-89. PubMed ID: 12746435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.
    Roberts LJ; Morrow JD
    Free Radic Biol Med; 2000 Feb; 28(4):505-13. PubMed ID: 10719231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel eicosanoids. Isoprostanes and related compounds.
    Roberts LJ; Brame CJ; Chen Y; Morrow JD
    Methods Mol Biol; 1999; 120():257-85. PubMed ID: 10343322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation.
    Milne GL; Musiek ES; Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):210-20. PubMed ID: 15650409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione.
    Morrow JD; Roberts LJ; Daniel VC; Awad JA; Mirochnitchenko O; Swift LL; Burk RF
    Arch Biochem Biophys; 1998 May; 353(1):160-71. PubMed ID: 9578611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.
    Morrow JD
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):279-86. PubMed ID: 15591226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans.
    Arneson KO; Roberts LJ
    Methods Enzymol; 2007; 433():127-43. PubMed ID: 17954232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation.
    Morrow JD; Chen Y; Brame CJ; Yang J; Sanchez SC; Xu J; Zackert WE; Awad JA; Roberts LJ
    Drug Metab Rev; 1999 Feb; 31(1):117-39. PubMed ID: 10065368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
    Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD
    Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophilic cyclopentenone isoprostanes in neurodegeneration.
    Musiek ES; McLaughlin B; Morrow JD
    J Mol Neurosci; 2007 Sep; 33(1):80-6. PubMed ID: 17901550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.
    Musiek ES; Breeding RS; Milne GL; Zanoni G; Morrow JD; McLaughlin B
    J Neurochem; 2006 Jun; 97(5):1301-13. PubMed ID: 16638022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.